ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $368,000 | -63.8% | 26,500 | -26.8% | 0.00% | -66.7% |
| Q4 2021 | $1,016,000 | -13.3% | 36,200 | +24.3% | 0.01% | -35.7% |
| Q1 2021 | $1,172,000 | -51.8% | 29,112 | -41.8% | 0.01% | -69.6% |
| Q3 2020 | $2,432,000 | +19.0% | 50,000 | +18.5% | 0.05% | +70.4% |
| Q2 2020 | $2,044,000 | +121.0% | 42,200 | +41.1% | 0.03% | 0.0% |
| Q3 2019 | $925,000 | -83.6% | 29,900 | -74.4% | 0.03% | -86.5% |
| Q2 2019 | $5,644,000 | – | 116,845 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |